After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Halozyme Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Halozyme Therapeutics Inc is $6.89B. A total of 2.02 million shares were traded on the day, compared to an average of 1.63M shares.
In the most recent transaction, Henderson Jeffrey William sold 10,000 shares of HALO for 50.01 per share on Jan 06 ’25. After the transaction, the Director now owns 43,611 company shares. In a previous transaction on Jan 06 ’25, JEFFREY HENDERSON bought 10,000 shares at 47.74 per share.
Among the insiders who sold shares, LaBarre Michael J. disposed of 10,000 shares on Oct 15 ’24 at a per-share price of $53.75. This resulted in the SVP, CHIEF TECHNICAL OFFICER holding 173,756 shares of HALO after the transaction. In another insider transaction, LaBarre Michael J. sold 10,000 shares at $53.26 per share on Oct 16 ’24. Company shares held by the SVP, CHIEF TECHNICAL OFFICER now total 173,756.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, HALO has a high of $65.53 and a low of $33.15.
As of this writing, HALO has an earnings estimate of $1.16 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of $1.23 per share and a lower estimate of $1.11.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. HALO’s latest balance sheet shows that the firm has $740.92M in Cash & Short Term Investments as of fiscal 2021. There were $876.67M in debt and $117.15M in liabilities at the time. Its Book Value Per Share was $3.56, while its Total Shareholder’s Equity was $196.95M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HALO is Buy with a score of 4.00.
